Avisi is a medical devices startup investigating the use of patented nanotechnology in an ocular implant to stop blindness in glaucoma patients.
Glaucoma is the second leading cause of blindness in the world and currently has no cure.
To date, Avisi has been supported by grants and awards from: the National Science Foundation, Ben Franklin Technology Partners, the University of Pennsylvania, Wharton, The School of Engineering and Applied Science, Venture Initiation Program Accelerator (VIP-X), Penn Law's Entrepreneurship Legal Clinic, VentureWell E-Teams, and Ballard Spahr BASE.
Avisi is a proud member of Johnson & Johnson JLABS incubator, UCSF Rosenman Innovators, OC OCTANE LaunchPad, and MedTech Innovator Accelerator.
Twitter: @avisi_tech
Website: www.avisitech.com
Location: United States, Pennsylvania, Philadelphia
Employees: 1-10
Total raised: $5.1M
Founded date: 2017
Investors 3
| Date | Name | Website |
| 05.01.2021 | Life Scien... | lifescienc... |
| - | Ben Frankl... | sep.benfra... |
| - | Good Growt... | goodgrowth... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 01.07.2022 | Seed | $4.1M | Life Scien... |
| 21.09.2020 | Grant | $1M | - |
Mentions in press and media 9
| Date | Title | Description | Source |
| 15.09.2022 | FY 2022: Ben Franklin Approved $11 Million in 48 Companies | To view details about each company, visit our directory page. Tech: Accencio Agora World Asy... | sep.benfra... |
| 12.08.2022 | Ben Franklin Approved $2.9M in 11 Early Stage Companies | Avisi is a pre-clinical stage medical devices company developing VisiPlate, a nanotechnology-... | sep.benfra... |
| 18.10.2021 | Ben Franklin Approved $2.1M in 12 Early Stage Companies | CrossBridge has reimagined Chronic Autoimmune Care. A SaaS specialty care platform is designed... | sep.benfra... |
| 27.10.2020 | Ben Franklin Approved $1.1M in 5 Early Stage Companies | Avisi Technologies: Avisi technologies is a pre-clinical stage company developing a nanotechno... | sep.benfra... |
| 21.09.2020 | Avisi Technologies eyes goal of human trials with $1M Nation... | RealLIST Startups 2020 honoree Avisi Technologies, maker of an ocular implant to treat glaucoma, is ... | technical.... |
| 02.03.2020 | CY: 2019 Ben Franklin Approved $4.6 Million in 28 Companies | To view details about each company, visit our directory page. Information Technology LeagueSide ... | sep.benfra... |
| 10.09.2019 | FY 2019: Ben Franklin Approved $7.2 Million in 46 Companies | Companies Approved: To view details about each company, visit our directory page. Information ... | sep.benfra... |
| 25.07.2019 | Ben Franklin Approved 1.3M in 9 Early Stage Companies | Avisi is a pre-clinical stage medical devices company developing VisiPlate, a nanotechnology-e... | sep.benfra... |
| - | Avisi Technologies | “Avisi Technologies is developing a nanotechnology-enabled defense against blindness from glaucoma.”... | fastfounde... |